Phase 3 Results of Bavarian Nordic’s Smallpox Vaccine Published in The New England Journal of Medicine

    NEXT STORY
    Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai
    PREV STORY
    Curetis Provides Business Update for the First Nine Months of 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    pSivida Submits Marketing Authorization Application (MAA) for Approval of Durasert™ Three-year Treatment for Posterior Segment Uveitis in the European Union

    WATERTOWN, Mass., June 22, 2017 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader ...

    author_avatar
    NASDAQ Market News

    BeyondSpring to Present Neutropenia Clinical Trial Data on Lead Asset, Plinabulin, at 2018 ASCO Annual Meeting

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Announces Presentations for its Endocrinology Rare Disease Clinical Programs at Upcoming Medical Conferences

    author_avatar
    NASDAQ Market News